Chen J, Singh K, Mukherjee B B, Sodek J
Medical Research Council Group in Periodontal Physiology, Faculty of Dentistry, University of Toronto, Ontario, Canada.
Matrix. 1993 Mar;13(2):113-23. doi: 10.1016/s0934-8832(11)80070-3.
Osteopontin (OPN) is a 34-kDa, highly-phosphorylated glycoprotein with cell attachment properties that is a prominent constituent of the bone matrix. To aid in elucidating the function of this protein we have studied the cellular expression of OPN mRNA during the formation, growth and maturation of rat calvarial (membranous) and tibial (endochondral) bone. From Northern hybridization analysis OPN expression was demonstrated in the kidney and gravid uterus as well as in bone tissues. Compared to collagen, the expression of OPN was low in early bone formation but increased subsequently and reached peak levels in 14-day-old bone. However, both the collagen and OPN mRNAs decreased markedly thereafter and remained low in young adult bone. From in situ hybridization studies using a [35S]-labelled rat OPN cRNA probe, OPN mRNA was localized to osteoblastic cells in newly-forming calvariae, jaw bones, and in the metaphyseal and periosteal bone of the tibia. In contrast to bone sialoprotein (BSP), which is expressed almost exclusively by osteoblasts at sites of de novo bone formation, OPN transcripts were present in cells lining both endosteal and periosteal bone surfaces, and in osteocytes. Moreover, expression of OPN persisted during the subsequent growth and remodelling of both membranous and endochondral bone and was expressed at particularly high levels by bone cells and hypertrophic chondrocytes at sites of osteoclastic resorption. In the more mature bone of young adult rats OPN expression was significantly reduced but remained detectable in bone cells lining periosteal and endosteal surfaces and in the primary and secondary spongiosa of the tibia. These studies on the developmental expression of OPN support the concept of a multifunctional role for OPN in bone formation and remodelling. Thus, the expression of OPN by osteoblasts early in bone development is consistent with a role for this protein in the formation of bone matrix, whereas the peak expression of OPN later in bone development, together with high expression at sites of rapid remodelling, indicate that OPN deposited on the surface of mineralized connective tissues may provide a template for osteoclastic resorption.
骨桥蛋白(OPN)是一种34 kDa的高度磷酸化糖蛋白,具有细胞黏附特性,是骨基质的主要成分。为了有助于阐明这种蛋白质的功能,我们研究了大鼠颅骨(膜性)和胫骨(软骨内)骨形成、生长和成熟过程中OPN mRNA的细胞表达情况。通过Northern杂交分析,在肾脏、妊娠子宫以及骨组织中均证实了OPN的表达。与胶原蛋白相比,OPN在早期骨形成中的表达较低,但随后增加,并在14日龄的骨中达到峰值水平。然而,此后胶原蛋白和OPN mRNA均显著下降,并在年轻成年骨中保持低水平。使用[35S]标记的大鼠OPN cRNA探针进行原位杂交研究,OPN mRNA定位于新形成的颅骨、颌骨以及胫骨干骺端和骨膜骨中的成骨细胞。与骨唾液蛋白(BSP)不同,BSP几乎仅在新生骨形成部位的成骨细胞中表达,而OPN转录本存在于骨内膜和骨膜骨表面的细胞以及骨细胞中。此外,在膜性骨和软骨内骨随后的生长和重塑过程中,OPN的表达持续存在,并且在破骨细胞吸收部位的骨细胞和肥大软骨细胞中表达水平特别高。在年轻成年大鼠更成熟的骨中,OPN表达显著降低,但在骨膜和骨内膜表面的骨细胞以及胫骨的初级和次级骨小梁中仍可检测到。这些关于OPN发育表达的研究支持了OPN在骨形成和重塑中具有多功能作用的概念。因此,成骨细胞在骨发育早期表达OPN与该蛋白在骨基质形成中的作用一致,而OPN在骨发育后期的峰值表达以及在快速重塑部位的高表达表明,沉积在矿化结缔组织表面的OPN可能为破骨细胞吸收提供模板。